Teva Pharmaceuticals: How Safe Is The High Dividend Yield?

Certain large pharmaceutical companies have proven to be excellent high-yield dividend growth stocks. However, due to the cyclical nature of the business, high R&D costs, and various regulatory risks, pharma can also be a very challenging industry in which to invest.

Let’s take a look at Teva Pharmaceuticals (NYSE:TEVA), one of the highest-yielding big pharma stocks available today, to see whether its recent challenges (and plunging share price) make it a possible opportunity for our Conservative Retirees dividend portfolio or a classic value trap to be avoided.

READ FULL ARTICLE HERE